Medicaid Health Plans of America

“Does it work, how well, and is it worth covering?” Dr. Maanasa Indaram and Stephanie Roberts walk through the clinical trial and real-world evidence behind Luminopia, the FDA-authorized treatment for pediatric amblyopia.
2026-09-01 14:00 - 15:00 (America/New_York)
Amblyopia is the leading cause of preventable vision loss in children, and standard-of-care treatment — patching the non-amblyopic eye — is hard on kids and families and leaves many with persistent amblyopia even after treatment. With that quick refresher in mind, this session turns to the evidence: does Luminopia work, how well, and is it worth covering?
We’ll briefly walk through the clinical development program, from pilot study through the pivotal Phase 3 RCT (Xiao et al., Ophthalmology 2021), before spending most of the session on real-world evidence from the PUPiL Registry. We’ll dig into registry outcomes across key subgroups — previously treated patients, older children, severe amblyopia, and by insurance/coverage type — along with durability of treatment effect after completion. We’ll close with health equity and access: real-world standard-of-care outcomes by insurance status, the uncovered cost burden of patching for Medicaid families, and cost-effectiveness data.
Learning Objectives

Get a quick refresher on amblyopia and the standard of care, and where it falls short for Medicaid-covered kids and families
Recognize health equity and access gaps in real-world standard-of-care outcomes by insurance status, and review budget impact
Briefly review the clinical development program and pivotal Phase 3 RCT results (Xiao et al., Ophthalmology 2021)
Dive into real-world evidence from the PUPiL Registry, including outcomes for previously treated patients, older children, severe amblyopia, and by insurance/coverage type, and durability after treatment completion
Preview emerging coverage considerations for health plans, including state Medicaid fee schedules and JMCP recommendations

Speakers

Maanasa Indaram, MD, Associate Professor of Ophthalmology and Medical Director, Pediatric Ophthalmology and Adult Strabismus, University of California, San Francisco
Stephanie Roberts, Head of Market Access, Luminopia, Inc.

Register Now

The Future of Payment Integrity: Opportunities for Managed Medicaid
2026-09-09 14:00 - 15:00
As managed Medicaid plans face growing regulatory scrutiny, increasing claim complexity, and mounting pressure to improve outcomes while controlling costs, a strategic approach to payment integrity has never been more important. Join Patrick Burcher, CEO, and Llyr Christensen, Vice President of Sales, for an insightful webinar, “The Future of Payment Integrity: Opportunities for Managed Medicaid.” This session will explore emerging trends shaping the health plan landscape and examine how payment integrity should be utilized to manage plan assets.

Attendees will gain practical insights into what defines a high-quality payment integrity strategy, including the importance of transparency, provider collaboration, use of advanced technology, and measurable outcomes. Patrick and Llyr will discuss common challenges facing managed Medicaid organizations today, opportunities to strengthen oversight, and key considerations for building a sustainable payment integrity program that supports both financial performance and member care.

Whether your organization is evaluating its current approach or planning for the future, this webinar will provide actionable guidance to help your team stay ahead in a rapidly changing healthcare environment.

Speakers
· Patrick Burcher, CEO, Catalyst Health
· Llyr Christensen, Vice President of Sales, Catalyst Health

Register Now
